Skip to main content
Top
Published in: BMC Infectious Diseases 1/2007

Open Access 01-12-2007 | Research article

Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia

Authors: Ifedayo MO Adetifa, Moses D Lugos, Abdulrahman Hammond, David Jeffries, Simon Donkor, Richard A Adegbola, Philip C Hill

Published in: BMC Infectious Diseases | Issue 1/2007

Login to get access

Abstract

Background

IFN-γ Release Assays (IGRAs) have been licensed for the diagnosis of latent Mycobacterium tuberculosis infection (LTBI). Their performance may depend on assay format and may vary across populations and settings. We compared the diagnostic performance of an in-house T -cell and commercial whole blood-based IGRAs for the diagnosis of LTBI and TB disease in The Gambia.

Methods

Newly diagnosed sputum smear positive cases and their household contacts were recruited. Cases and contacts were bled for IGRA and contacts had a Mantoux skin test. We assessed agreement and discordance between the tests and categorized a contact's level of M. tuberculosis exposure according to where s/he slept relative to a case: the same room, same house or a different house. We assessed the relationship between exposure and test results by multiple logistic regression.

Results

In 80 newly diagnosed TB cases, the sensitivity of ELISPOT was 78.7% and for QFT-GIT was 64.0% (p = 0.047). Of 194 household contacts 57.1% and 58.8% were positive for ELISPOT and QFT-GIT respectively. The overall agreement between both IGRAs for LTBI in contacts was 71.4% and there was no significant discordance (p = 0.29). There was significant discordance between the IGRAs and TST. Neither IGRA nor TST had evidence of false positive results because of Bacille Calmette Guérin (BCG) vaccination. However, agreement between QFT-GIT and TST as well as discordance between both IGRAs and TST were associated with BCG vaccination. Both IGRAs responded to the M. tuberculosis exposure gradient and were positively associated with increasing TST induration (p = 0.003 for ELISPOT and p = 0.001 for QFT-GIT).

Conclusion

The ELISPOT test is more sensitive than the QFT-GIT for diagnosing TB disease. The two tests perform similarly in the diagnosis of LTBI in TB contacts. Significant discordance between the two IGRAs and between each and the TST remain largely unexplained.
Appendix
Available only for authorised users
Literature
2.
go back to reference Pitman R, Jarman B, Coker R: Tuberculosis transmission and the impact of intervention on the incidence of infection. Int J Tuberc Lung Dis. 2002, 6: 485-491.PubMed Pitman R, Jarman B, Coker R: Tuberculosis transmission and the impact of intervention on the incidence of infection. Int J Tuberc Lung Dis. 2002, 6: 485-491.PubMed
3.
go back to reference Jasmer RM, Nahid P, Hopewell PC: Clinical practice. Latent tuberculosis infection. N Engl J Med. 2002, 347: 1860-1866. 10.1056/NEJMcp021045.CrossRefPubMed Jasmer RM, Nahid P, Hopewell PC: Clinical practice. Latent tuberculosis infection. N Engl J Med. 2002, 347: 1860-1866. 10.1056/NEJMcp021045.CrossRefPubMed
4.
go back to reference Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, Ngwira B, Sichali L, Nazareth B, Blackwell JM, Branson K, Chaguluka SD, Donovan L, Jarman E, King E, Fine PE, Dockrell HM: BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet. 2002, 359: 1393-1401. 10.1016/S0140-6736(02)08353-8.CrossRefPubMed Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, Ngwira B, Sichali L, Nazareth B, Blackwell JM, Branson K, Chaguluka SD, Donovan L, Jarman E, King E, Fine PE, Dockrell HM: BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet. 2002, 359: 1393-1401. 10.1016/S0140-6736(02)08353-8.CrossRefPubMed
5.
6.
go back to reference Pai M, Riley LW, Colford JM: Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004, 4: 761-776. 10.1016/S1473-3099(04)01206-X.CrossRefPubMed Pai M, Riley LW, Colford JM: Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004, 4: 761-776. 10.1016/S1473-3099(04)01206-X.CrossRefPubMed
7.
go back to reference Menzies D, Pai M, Comstock G: Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007, 146: 340-354.CrossRefPubMed Menzies D, Pai M, Comstock G: Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007, 146: 340-354.CrossRefPubMed
8.
go back to reference Dinnes J, Deeks J, Kunst H, Gibson A, Cummins E, Waugh N, Drobniewski F, Lalvani A: A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess. 2007, 11: 1-196.CrossRefPubMed Dinnes J, Deeks J, Kunst H, Gibson A, Cummins E, Waugh N, Drobniewski F, Lalvani A: A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess. 2007, 11: 1-196.CrossRefPubMed
9.
go back to reference Heifets LB, Good RB: Current laboratory methods for the diagnosis of tuberculosis. Tuberculosis: protection, pathogenesis, and control. Edited by: Bloom BR. 1994, Washington, DC, American Society for Microbiology, 85-110.CrossRef Heifets LB, Good RB: Current laboratory methods for the diagnosis of tuberculosis. Tuberculosis: protection, pathogenesis, and control. Edited by: Bloom BR. 1994, Washington, DC, American Society for Microbiology, 85-110.CrossRef
10.
go back to reference Adegbola RA, Hill P, Baldeh I, Otu J, Sarr R, Sillah J, Lienhardt C, Corrah T, Manneh K, Drobniewski F, McAdam KP: Surveillance of drug-resistant Mycobacterium tuberculosis in The Gambia. Int J Tuberc Lung Dis. 2003, 7: 390-393.PubMed Adegbola RA, Hill P, Baldeh I, Otu J, Sarr R, Sillah J, Lienhardt C, Corrah T, Manneh K, Drobniewski F, McAdam KP: Surveillance of drug-resistant Mycobacterium tuberculosis in The Gambia. Int J Tuberc Lung Dis. 2003, 7: 390-393.PubMed
11.
go back to reference Lalvani A, Brookes R, Hambleton S, Britton WJ, Hill AV, McMichael AJ: Rapid effector function in CD8+ memory T cells. J Exp Med. 1997, 186: 859-865. 10.1084/jem.186.6.859.CrossRefPubMedPubMedCentral Lalvani A, Brookes R, Hambleton S, Britton WJ, Hill AV, McMichael AJ: Rapid effector function in CD8+ memory T cells. J Exp Med. 1997, 186: 859-865. 10.1084/jem.186.6.859.CrossRefPubMedPubMedCentral
12.
go back to reference Jeffries DJ, Hill PC, Fox A, Lugos M, Jackson-Sillah DJ, Adegbola RA, Brookes RH: Identifying ELISPOT and skin test cut-offs for diagnosis of Mycobacterium tuberculosis infection in The Gambia. Int J Tuberc Lung Dis. 2006, 10: 192-198.PubMed Jeffries DJ, Hill PC, Fox A, Lugos M, Jackson-Sillah DJ, Adegbola RA, Brookes RH: Identifying ELISPOT and skin test cut-offs for diagnosis of Mycobacterium tuberculosis infection in The Gambia. Int J Tuberc Lung Dis. 2006, 10: 192-198.PubMed
13.
go back to reference http://www.cellestis.com: QuantiFERON-TB Gold In-Tube: technical information. http://www.cellestis.com: QuantiFERON-TB Gold In-Tube: technical information.
14.
go back to reference Lienhardt C, Fielding K, Sillah J, Tunkara A, Donkor S, Manneh K, Warndorff D, McAdam KP, Bennett S: Risk factors for tuberculosis infection in sub-Saharan Africa: a contact study in The Gambia. Am J Respir Crit Care Med. 2003, 168: 448-455. 10.1164/rccm.200212-1483OC.CrossRefPubMed Lienhardt C, Fielding K, Sillah J, Tunkara A, Donkor S, Manneh K, Warndorff D, McAdam KP, Bennett S: Risk factors for tuberculosis infection in sub-Saharan Africa: a contact study in The Gambia. Am J Respir Crit Care Med. 2003, 168: 448-455. 10.1164/rccm.200212-1483OC.CrossRefPubMed
15.
go back to reference Hill PC, Brookes RH, Fox A, Fielding K, Jeffries DJ, Jackson-Sillah D, Lugos MD, Owiafe PK, Donkor SA, Hammond AS, Otu JK, Corrah T, Adegbola RA, McAdam KP: Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis. 2004, 38: 966-973. 10.1086/382362.CrossRefPubMed Hill PC, Brookes RH, Fox A, Fielding K, Jeffries DJ, Jackson-Sillah D, Lugos MD, Owiafe PK, Donkor SA, Hammond AS, Otu JK, Corrah T, Adegbola RA, McAdam KP: Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis. 2004, 38: 966-973. 10.1086/382362.CrossRefPubMed
16.
go back to reference Aiken AM, Hill PC, Fox A, McAdam KP, Jackson-Sillah D, Lugos MD, Donkor SA, Adegbola RA, Brookes RH: Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis. 2006, 6: 66-10.1186/1471-2334-6-66.CrossRefPubMedPubMedCentral Aiken AM, Hill PC, Fox A, McAdam KP, Jackson-Sillah D, Lugos MD, Donkor SA, Adegbola RA, Brookes RH: Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis. 2006, 6: 66-10.1186/1471-2334-6-66.CrossRefPubMedPubMedCentral
17.
go back to reference Dewan PK, Grinsdale J, Kawamura LM: Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis. 2007, 44: 69-73. 10.1086/509928.CrossRefPubMed Dewan PK, Grinsdale J, Kawamura LM: Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis. 2007, 44: 69-73. 10.1086/509928.CrossRefPubMed
18.
go back to reference Lee JY, Choi HJ, Park IN, Hong SB, Oh YM, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS: Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J. 2006, 28: 24-30. 10.1183/09031936.06.00016906.CrossRefPubMed Lee JY, Choi HJ, Park IN, Hong SB, Oh YM, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS: Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J. 2006, 28: 24-30. 10.1183/09031936.06.00016906.CrossRefPubMed
19.
go back to reference Tsiouris SJ, Coetzee D, Toro PL, Austin J, Stein Z, El-Sadr W: Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol. 2006, 44: 2844-2850. 10.1128/JCM.02411-05.CrossRefPubMedPubMedCentral Tsiouris SJ, Coetzee D, Toro PL, Austin J, Stein Z, El-Sadr W: Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol. 2006, 44: 2844-2850. 10.1128/JCM.02411-05.CrossRefPubMedPubMedCentral
20.
go back to reference Goletti D, Carrara S, Vincenti D, Saltini C, Rizzi EB, Schinina V, Ippolito G, Amicosante M, Girardi E: Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study. Clin Microbiol Infect. 2006, 12: 544-550. 10.1111/j.1469-0691.2006.01391.x.CrossRefPubMed Goletti D, Carrara S, Vincenti D, Saltini C, Rizzi EB, Schinina V, Ippolito G, Amicosante M, Girardi E: Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study. Clin Microbiol Infect. 2006, 12: 544-550. 10.1111/j.1469-0691.2006.01391.x.CrossRefPubMed
21.
go back to reference Ferrara G, Losi M, D'Amico R, Roversi P, Piro R, Meacci M, Meccugni B, Dori IM, Andreani A, Bergamini BM, Mussini C, Rumpianesi F, Fabbri LM, Richeldi L: Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet. 2006, 367: 1328-1334. 10.1016/S0140-6736(06)68579-6.CrossRefPubMed Ferrara G, Losi M, D'Amico R, Roversi P, Piro R, Meacci M, Meccugni B, Dori IM, Andreani A, Bergamini BM, Mussini C, Rumpianesi F, Fabbri LM, Richeldi L: Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet. 2006, 367: 1328-1334. 10.1016/S0140-6736(06)68579-6.CrossRefPubMed
22.
go back to reference Dogra S, Narang P, Mendiratta DK, Chaturvedi P, Reingold AL, Colford JM, Riley LW, Pai M: Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infect. 2007, 54: 267-276. 10.1016/j.jinf.2006.04.007.CrossRefPubMed Dogra S, Narang P, Mendiratta DK, Chaturvedi P, Reingold AL, Colford JM, Riley LW, Pai M: Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infect. 2007, 54: 267-276. 10.1016/j.jinf.2006.04.007.CrossRefPubMed
23.
go back to reference Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I: Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med. 2004, 170: 59-64. 10.1164/rccm.200402-179OC.CrossRefPubMed Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I: Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med. 2004, 170: 59-64. 10.1164/rccm.200402-179OC.CrossRefPubMed
24.
go back to reference Detjen AK, Keil T, Roll S, Hauer B, Mauch H, Wahn U, Magdorf K: Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis. 2007, 45: 322-328. 10.1086/519266.CrossRefPubMed Detjen AK, Keil T, Roll S, Hauer B, Mauch H, Wahn U, Magdorf K: Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis. 2007, 45: 322-328. 10.1086/519266.CrossRefPubMed
25.
go back to reference Kang YA, Lee HW, Hwang SS, Um SW, Han SK, Shim YS, Yim JJ: Usefulness of Whole-Blood Interferon-{gamma} Assay and Interferon-{gamma} Enzyme-Linked Immunospot Assay in the Diagnosis of Active Pulmonary Tuberculosis. Chest. 2007, 132: 959-965. 10.1378/chest.06-2805.CrossRefPubMed Kang YA, Lee HW, Hwang SS, Um SW, Han SK, Shim YS, Yim JJ: Usefulness of Whole-Blood Interferon-{gamma} Assay and Interferon-{gamma} Enzyme-Linked Immunospot Assay in the Diagnosis of Active Pulmonary Tuberculosis. Chest. 2007, 132: 959-965. 10.1378/chest.06-2805.CrossRefPubMed
26.
go back to reference Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF, Cobelens FG, van Houte AJ, Bossink AW: Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med. 2007, 175: 618-627. 10.1164/rccm.200608-1099OC.CrossRefPubMed Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF, Cobelens FG, van Houte AJ, Bossink AW: Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med. 2007, 175: 618-627. 10.1164/rccm.200608-1099OC.CrossRefPubMed
27.
go back to reference Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T: Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol. 2006, 27: 442-448. 10.1086/504358.CrossRefPubMed Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T: Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol. 2006, 27: 442-448. 10.1086/504358.CrossRefPubMed
28.
go back to reference Diel R, Nienhaus A, Lange C, Meywald-Walter K, Forssbohm M, Schaberg T: Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res. 2006, 7: 77-10.1186/1465-9921-7-77.CrossRefPubMedPubMedCentral Diel R, Nienhaus A, Lange C, Meywald-Walter K, Forssbohm M, Schaberg T: Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res. 2006, 7: 77-10.1186/1465-9921-7-77.CrossRefPubMedPubMedCentral
29.
go back to reference Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, Yim JJ: Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. Jama. 2005, 293: 2756-2761. 10.1001/jama.293.22.2756.CrossRefPubMed Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, Yim JJ: Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. Jama. 2005, 293: 2756-2761. 10.1001/jama.293.22.2756.CrossRefPubMed
30.
go back to reference Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries DJ, Lugos MD, Donkor SA, Adetifa IM, de Jong BC, Aiken AM, Adegbola RA, McAdam KP: Longitudinal Assessment of an ELISPOT Test for Mycobacterium tuberculosis Infection. PLoS Med. 2007, 4: e192-10.1371/journal.pmed.0040192.CrossRefPubMedPubMedCentral Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries DJ, Lugos MD, Donkor SA, Adetifa IM, de Jong BC, Aiken AM, Adegbola RA, McAdam KP: Longitudinal Assessment of an ELISPOT Test for Mycobacterium tuberculosis Infection. PLoS Med. 2007, 4: e192-10.1371/journal.pmed.0040192.CrossRefPubMedPubMedCentral
31.
go back to reference Pai M, Menzies D: The new IGRA and the old TST: making good use of disagreement. Am J Respir Crit Care Med. 2007, 175: 529-531. 10.1164/rccm.200701-024ED.CrossRefPubMed Pai M, Menzies D: The new IGRA and the old TST: making good use of disagreement. Am J Respir Crit Care Med. 2007, 175: 529-531. 10.1164/rccm.200701-024ED.CrossRefPubMed
32.
go back to reference Hill PC, Brookes RH, Adetifa IM, Fox A, Jackson-Sillah D, Lugos MD, Donkor SA, Marshall RJ, Howie SR, Corrah T, Jeffries DJ, Adegbola RA, McAdam KP: Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics. 2006, 117: 1542-1548. 10.1542/peds.2005-2095.CrossRefPubMed Hill PC, Brookes RH, Adetifa IM, Fox A, Jackson-Sillah D, Lugos MD, Donkor SA, Marshall RJ, Howie SR, Corrah T, Jeffries DJ, Adegbola RA, McAdam KP: Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics. 2006, 117: 1542-1548. 10.1542/peds.2005-2095.CrossRefPubMed
33.
go back to reference Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, Narang P, Daley CL, Granich RM, Mazurek GH, Reingold AL, Riley LW, Colford JM: Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA. 2005, 293: 2746-2755. 10.1001/jama.293.22.2746.CrossRefPubMed Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, Narang P, Daley CL, Granich RM, Mazurek GH, Reingold AL, Riley LW, Colford JM: Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA. 2005, 293: 2746-2755. 10.1001/jama.293.22.2746.CrossRefPubMed
34.
go back to reference Mudido PM, Guwatudde D, Nakakeeto MK, Bukenya GB, Nsamba D, Johnson JL, Mugerwa RD, Ellner JJ, Whalen CC: The effect of bacille Calmette-Guerin vaccination at birth on tuberculin skin test reactivity in Ugandan children. Int J Tuberc Lung Dis. 1999, 3: 891-895.PubMed Mudido PM, Guwatudde D, Nakakeeto MK, Bukenya GB, Nsamba D, Johnson JL, Mugerwa RD, Ellner JJ, Whalen CC: The effect of bacille Calmette-Guerin vaccination at birth on tuberculin skin test reactivity in Ugandan children. Int J Tuberc Lung Dis. 1999, 3: 891-895.PubMed
35.
go back to reference Almeida LM, Barbieri MA, Da Paixao AC, Cuevas LE: Use of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a population with high Calmette-Guerin bacillus coverage. Pediatr Infect Dis J. 2001, 20: 1061-1065. 10.1097/00006454-200111000-00011.CrossRefPubMed Almeida LM, Barbieri MA, Da Paixao AC, Cuevas LE: Use of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a population with high Calmette-Guerin bacillus coverage. Pediatr Infect Dis J. 2001, 20: 1061-1065. 10.1097/00006454-200111000-00011.CrossRefPubMed
36.
go back to reference Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM: A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax. 2002, 57: 804-809. 10.1136/thorax.57.9.804.CrossRefPubMedPubMedCentral Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM: A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax. 2002, 57: 804-809. 10.1136/thorax.57.9.804.CrossRefPubMedPubMedCentral
37.
go back to reference Igari H, Watanabe A, Sato T: Booster phenomenon of QuantiFERON-TB Gold after prior intradermal PPD injection. Int J Tuberc Lung Dis. 2007, 11: 788-791.PubMed Igari H, Watanabe A, Sato T: Booster phenomenon of QuantiFERON-TB Gold after prior intradermal PPD injection. Int J Tuberc Lung Dis. 2007, 11: 788-791.PubMed
38.
go back to reference Leyten EM, Prins C, Bossink AW, Thijsen S, Ottenhoff TH, van Dissel JT, Arend SM: Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay. Eur Respir J. 2007, 29: 1212-1216. 10.1183/09031936.00117506.CrossRefPubMed Leyten EM, Prins C, Bossink AW, Thijsen S, Ottenhoff TH, van Dissel JT, Arend SM: Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay. Eur Respir J. 2007, 29: 1212-1216. 10.1183/09031936.00117506.CrossRefPubMed
39.
go back to reference Naseer A, Naqvi S, Kampmann B: Evidence for boosting Mycobacterium tuberculosis-specific IFN-gamma responses at 6 weeks following tuberculin skin testing. Eur Respir J. 2007, 29: 1282-1283. 10.1183/09031936.00017807.CrossRefPubMed Naseer A, Naqvi S, Kampmann B: Evidence for boosting Mycobacterium tuberculosis-specific IFN-gamma responses at 6 weeks following tuberculin skin testing. Eur Respir J. 2007, 29: 1282-1283. 10.1183/09031936.00017807.CrossRefPubMed
40.
go back to reference Oxford Immunotec: T-SPOT.TB. An aid in the diagnosis of tuberculosis infection. VISUAL PROCEDURE GUIDE. For in vitro diagnostic use. Accessed 2nd May 2007. 2006, http://www.oxfordimmunotec.com/downloads/Visual%20Procedure%20Guide%20(English),%20VPG-TB-UK-V4%20070706.pdf Oxford Immunotec: T-SPOT.TB. An aid in the diagnosis of tuberculosis infection. VISUAL PROCEDURE GUIDE. For in vitro diagnostic use. Accessed 2nd May 2007. 2006, http://​www.​oxfordimmunotec.​com/​downloads/​Visual%20Procedure%20Guide%20(English),%20VPG-TB-UK-V4%20070706.pdf
Metadata
Title
Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia
Authors
Ifedayo MO Adetifa
Moses D Lugos
Abdulrahman Hammond
David Jeffries
Simon Donkor
Richard A Adegbola
Philip C Hill
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2007
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-7-122

Other articles of this Issue 1/2007

BMC Infectious Diseases 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.